Target Group Inc. SEC filings CBDY
Target Group Inc. has 254 filings in SEC EDGAR's recent list, going back to Sep 30, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 18, 2025 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 5, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 10-Q/A | Amended quarterly report | Jun 12, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Jun 5, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 19, 2019 | Sep 30, 2019 |
| 10-Q/A | Amended quarterly report | Aug 20, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | Aug 19, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 20, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 15, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 3, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 14, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 15, 2017 | Mar 31, 2017 |
| 10-Q/A | Amended quarterly report | Nov 17, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Nov 14, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 11, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 12, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 16, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 14, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 13, 2015 | Mar 31, 2015 |
| 10-Q/A | Amended quarterly report | Jan 26, 2015 | Sep 30, 2014 |
| 10-Q/A | Amended quarterly report | Jan 26, 2015 | Jun 30, 2014 |
| 10-Q/A | Amended quarterly report | Jan 26, 2015 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 17, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 14, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 15, 2014 | Mar 31, 2014 |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CBDY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hamilton
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1586554
- Former names
- Chess Supersite Corp (until Jul 3, 2018); River Run Acquisition Corp (until May 13, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.